This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Thierry Canton: Innovator in Cerebellar Dysfunction Treatment
Introduction
Thierry Canton is a notable inventor based in Etrechy, France. He has made significant contributions to the field of medicine, particularly in the treatment of cerebellar dysfunction. His innovative approach has led to the development of a unique patent that addresses a critical health issue.
Latest Patents
Thierry Canton holds a patent for the "Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction." This patent outlines a method for preventing or treating cerebellar dysfunction, specifically cerebellar ataxia, through the use of riluzole or a pharmaceutically acceptable salt thereof. This invention represents a significant advancement in therapeutic options for patients suffering from this condition.
Career Highlights
Canton is associated with Aventis Pharma S.A., a prominent pharmaceutical company. His work there has allowed him to collaborate with other talented professionals in the field. His dedication to research and innovation has positioned him as a key figure in the development of new treatment methodologies.
Collaborations
Throughout his career, Thierry Canton has worked alongside esteemed colleagues such as Andrees Bohme and Alain Boireau. These collaborations have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
In summary, Thierry Canton is a distinguished inventor whose work in the treatment of cerebellar dysfunction has made a meaningful impact in the medical field. His patent and collaborations highlight his commitment to advancing healthcare solutions.